Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc.（AMRX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
amrx · 股价预测 · 16 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 16 位华尔街分析师
Buy
16 位分析师
共识
评级分布
12 个月目标价
High
$19.00
Consensus
$17.33
+26.0% upside
Low
$16.00
Median: $17 · Last Close: $13.75
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$17.33
26.0% upside
High Target
$19
38.2%
Low Target
$16
16.4%
Current Price
$13.75
as of today
Based on analyst price targets, the AMRX stock price prediction for the next 12 months ranges from $16 to $19. The consensus AMRX price forecast of $17.33 implies 26.0% upside from the current price of $13.75.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.06 | ↑ 2.27% |
1-day model range: $14.01–$14.11. Peak: $14.11 (+2.27%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $22 | +60.9% |
| 2028 | $30 | +119.8% |
| 2029 | $37 | +168.0% |
| 2030 | $42 | +203.3% |
| 2031 | — | +227.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AMRX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-20 | Barclays | Maintains | Overweight→Overweight |
| 2026-03-02 | Truist Securities | Maintains | Buy→Buy |
| 2025-10-31 | Piper Sandler | Maintains | Overweight→Overweight |
| 2025-09-16 | JP Morgan | Maintains | Overweight→Overweight |
| 2025-03-03 | Barclays | Maintains | Overweight→Overweight |
| 2025-02-24 | JP Morgan | Upgrade ↑ | Neutral→Overweight |
| 2024-11-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2024-10-02 | Truist Securities | Maintains | Buy→Buy |
| 2024-09-06 | JP Morgan | Upgrade ↑ | Underweight→Neutral |
| 2024-08-13 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Amneal Pharmaceuticals, Inc. (AMRX) stock. Of the recent 67 rating actions, 10 were upgrades and 7 were downgrades. 16 analysts currently cover AMRX.
分析师推荐趋势
AMRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$2.8B
↓ 10.7% YoY
Revenue Next Year
$3.0B
↑ 8.7% YoY
EPS This Year
$0.61
EPS Next Year
$0.80
↑ 30.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast AMRX EPS of $0.61 for the current fiscal year, based on estimates from 3 analysts. The AMRX revenue forecast is $2.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AMRX 股价预测由两类独立数据源支撑：来自 16 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AMRX 的共识目标价为 $17.33（+26.0% 上行空间），分析师共识为 Buy。
AMRX 的短期预测（明日）为 $14.06（+2.27%）。 AMRX 对 2027 年的股价预测均值为 $22。 AMRX 对 2030 年的预测区间为 $40–$43。
Amneal Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 AMRX。AMRX 在 2027 年的整体展望偏积极，在覆盖分析师中约 63% 对应 Buy 共识。
常见问题
AMRX 预测 · 8 个问题根据 16 位华尔街分析师，AMRX 的 12 个月平均目标价为 $17.33，最高 $19.00、最低 $16.00。若有图表，中位目标价可在上方查看。相对当前价 $13.75，隐含约 +26.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.